Back to Search
Start Over
Systemic proteomic and metabolomic signature of the SGLT2 inhibitor dapagliflozin.
- Source :
- FASEB Journal; May2022 Supplement, Vol. 36, pN.PAG-N.PAG, 1p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 08926638
- Volume :
- 36
- Database :
- Complementary Index
- Journal :
- FASEB Journal
- Publication Type :
- Academic Journal
- Accession number :
- 173139960
- Full Text :
- https://doi.org/10.1096/fasebj.2022.36.S1.R4450